Efficacy and Tolerability of the Carboplatin, Paclitaxel, Cetuximab (CTE) Regimen for Head and Neck Squamous Cell Carcinomas
This paper has been withdrawn.
Jun 1st, 12:00 AM
Efficacy and Tolerability of the Carboplatin, Paclitaxel, Cetuximab (CTE) Regimen for Head and Neck Squamous Cell Carcinomas